Tofranil-PM

Tofranil-PM is a brand name of imipramine, approved by the FDA in the following formulation(s):

TOFRANIL-PM (imipramine pamoate - capsule; oral)

• 
  Manufacturer: MALLINCKRODT INC
  
  Approved Prior to Jan 1, 1982
  
  Strength(s): EQ 100MG HCL ^[AB], EQ 125MG HCL ^[AB], EQ 150MG HCL ^[AB], EQ 75MG HCL ^[RLD][AB]

Has a generic version of Tofranil-PM been approved?

Yes. The following products are equivalent to Tofranil-PM:

imipramine pamoate capsule; oral

• 
  Manufacturer: LUPIN LTD
  
  Approval date: April 16, 2010
  
  Strength(s): EQ 100MG HCL ^[AB], EQ 125MG HCL ^[AB], EQ 150MG HCL ^[AB], EQ 75MG HCL ^[AB]


• 
  Manufacturer: ROXANE
  
  Approval date: April 16, 2010
  
  Strength(s): EQ 100MG HCL ^[AB], EQ 125MG HCL ^[AB], EQ 150MG HCL ^[AB], EQ 75MG HCL ^[AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Tofranil-PM. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.

Related Patents

There are no current U.S. patents associated with Tofranil-PM.

See also...

• Tofranil-PM Consumer Information (Wolters Kluwer)
• Tofranil-PM Consumer Information (Cerner Multum)
• Tofranil-PM Advanced Consumer Information (Micromedex)
• Imipramine Consumer Information (Wolters Kluwer)
• Imipramine Capsules Consumer Information (Wolters Kluwer)
• Imipramine Consumer Information (Cerner Multum)
• Imipramine Advanced Consumer Information (Micromedex)
• Imipramine Hydrochloride AHFS DI Monographs (ASHP)
• Imipramine Pamoate AHFS DI Monographs (ASHP)